Tudor Investment Corp ET AL Trims Stock Holdings in Aehr Test Systems $AEHR

Key Points

• Tudor Investment Corp ET AL cut its stake in Aehr Test Systems by 18%, selling 39,004 shares and finishing the quarter with 178,040 shares (about $5.36M, or 0.59% of the company).
• Other institutions increased exposure—Vanguard added shares to reach 2,288,190, Invesco jumped ~1,137% to 366,570 shares, and William Blair opened a new ~$26.9M position—leaving hedge funds owning roughly 69.7% of the stock.
• Aehr beat EPS expectations (‑$0.05 vs. ‑$0.07 est.) but missed revenue ($10.31M vs. ~$10.85M), while reporting ~$37.2M in bookings and a $50.9M backlog that improves revenue visibility; the company also launched a $60M ATM offering that may dilute shareholders.

Tudor Investment Corp ET AL decreased its holdings in Aehr Test Systems (NASDAQ:AEHR - Free Report) by 18.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 178,040 shares of the semiconductor company's stock after selling 39,004 shares during the period. Tudor Investment Corp ET AL owned 0.59% of Aehr Test Systems worth $5,361,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of Aehr Test Systems by 2.9% in the third quarter. Vanguard Group Inc. now owns 2,288,190 shares of the semiconductor company's stock worth $68,897,000 after purchasing an additional 65,444 shares in the last quarter. William Blair Investment Management LLC purchased a new position in shares of Aehr Test Systems in the third quarter worth about $26,920,000. Halter Ferguson Financial Inc. grew its stake in Aehr Test Systems by 3.0% during the third quarter. Halter Ferguson Financial Inc. now owns 453,012 shares of the semiconductor company's stock valued at $13,640,000 after acquiring an additional 13,298 shares in the last quarter. Invesco Ltd. grew its stake in Aehr Test Systems by 1,137.2% during the third quarter. Invesco Ltd. now owns 366,570 shares of the semiconductor company's stock valued at $11,037,000 after acquiring an additional 336,940 shares in the last quarter. Finally, Wellington Management Group LLP grew its stake in Aehr Test Systems by 33.4% during the third quarter. Wellington Management Group LLP now owns 361,264 shares of the semiconductor company's stock valued at $10,878,000 after acquiring an additional 90,413 shares in the last quarter. Hedge funds and other institutional investors own 69.69% of the company's stock.

Aehr Test Systems Stock Performance

Shares of AEHR opened at $63.16 on Thursday. The firm has a market cap of $1.93 billion, a price-to-earnings ratio of -210.53 and a beta of 2.28. Aehr Test Systems has a fifty-two week low of $6.90 and a fifty-two week high of $66.28. The firm has a 50 day moving average price of $35.92 and a 200-day moving average price of $28.92.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last issued its earnings results on Tuesday, April 7th. The semiconductor company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.02. Aehr Test Systems had a negative net margin of 16.63% and a negative return on equity of 4.57%. The company had revenue of $10.31 million for the quarter, compared to the consensus estimate of $10.85 million. As a group, equities research analysts predict that Aehr Test Systems will post 0.1 earnings per share for the current year.

Insider Buying and Selling at Aehr Test Systems

In related news, Director Rhea J. Posedel sold 13,998 shares of Aehr Test Systems stock in a transaction on Friday, February 13th. The shares were sold at an average price of $30.02, for a total value of $420,219.96. Following the transaction, the director directly owned 456,979 shares of the company's stock, valued at $13,718,509.58. The trade was a 2.97% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Laura Oliphant sold 4,546 shares of Aehr Test Systems stock in a transaction on Thursday, January 22nd. The stock was sold at an average price of $31.40, for a total transaction of $142,744.40. Following the completion of the transaction, the director directly owned 18,432 shares in the company, valued at approximately $578,764.80. The trade was a 19.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 6.80% of the stock is owned by insiders.

Key Aehr Test Systems News

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Company reported a smaller-than-expected quarterly loss (beat EPS estimates) which relieved near-term earnings concerns and helped push the stock higher. Why Aehr Test Systems Stock Skyrocketed Today
• Positive Sentiment: Large bookings surge: the company reported ~$37.2M in quarterly bookings and an effective backlog of $50.9M, and is targeting the high side of $45M–$50M for FY2026 — this materially improves revenue visibility. Aehr Test Systems (AEHR) Stock Soars 27% on Massive Bookings Inflection and AI Orders
• Positive Sentiment: Company press release and earnings call highlighted bookings driven by AI, silicon photonics and data-center customers — supports a multi-quarter revenue runway if orders convert. Aehr Test Systems Reports Over $37 Million in Quarterly Bookings Driven by Strong AI and Data Center Infrastructure Demand
• Positive Sentiment: Multiple articles frame Aehr as a strategic, under-the-radar play in AI infrastructure (burn‑in/test systems for chips), which can drive re-rating if the narrative gains traction with institutional investors. Aehr Test Systems: The Quiet Bottleneck In AI Infrastructure
• Neutral Sentiment: Company filed a $60M ATM equity distribution agreement — provides capital to fund growth and backlog conversion but may dilute existing shareholders if shares are issued. Aehr Test Systems Launches $60 Million ATM Offering
• Neutral Sentiment: Unusually large call‑option volume was reported — signals speculative bullish positioning that can amplify intraday moves but doesn't change fundamentals. Traders Buy Large Volume of Call Options on Aehr Test Systems NASDAQ: AEHR
• Negative Sentiment: Revenue missed consensus for the quarter (reported $10.31M vs. ~$10.85M est.), a reminder that bookings must convert to shipments and revenue — investors may worry about near‑term top‑line execution. Aehr Test Systems (AEHR) Reports Q3 Loss, Misses Revenue Estimates
• Negative Sentiment: Some outlets noted the stock had slipped in after‑hours trading earlier after the report — highlights profit‑taking risk and sensitivity to execution details. Aehr Test Systems misses revenue projections. Its stock falls after hot streak.

Wall Street Analyst Weigh In

Several brokerages recently commented on AEHR. William Blair raised shares of Aehr Test Systems from a "market perform" rating to an "outperform" rating in a research note on Monday, March 2nd. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Aehr Test Systems in a research note on Wednesday, January 21st. Craig Hallum raised shares of Aehr Test Systems from a "hold" rating to a "buy" rating and set a $68.00 price objective for the company in a research note on Wednesday. Finally, Lake Street Capital began coverage on shares of Aehr Test Systems in a report on Wednesday, December 17th. They issued a "buy" rating for the company. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Aehr Test Systems presently has an average rating of "Hold" and an average target price of $68.00.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company's product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.

Want to see what other hedge funds are holding AEHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aehr Test Systems (NASDAQ:AEHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.